Doctors can accurately predict a person's risk of fatty liver disease as early as 16 years before symptoms develop, a new ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) ...

SINCE the last review of alcoholic fatty liver in this journal ... and the departments of Medicine and Pathology, Mount Sinai School of Medicine, City University of New York (address reprint ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

University of Kentucky Markey Cancer Center researchers have identified a mechanism by which a gut hormone contributes to ...

Nonalcoholic fatty liver disease (NAFLD ... and focus on current discussions related to the specific lesions in the pathology of NASH, including the challenges of pediatric NASH and NASH-related ...

"Right now, when I see patients with early-stage fatty liver disease ... The American Journal of Pathology (2024). DOI: ...

Nonalcoholic fatty liver disease (NAFLD ... in reducing the NAFLD-induced inflammation and improving cellular histology. Successful treatment will need to include genetic or molecular-level ...

Parenteral nutrition (PN) is lifesaving for patients with short bowel syndrome and other gastrointestinal disorders, however long-term use may lead to complications including hepatosteatosis and ...